APA (7th ed.) Citation

Tesileanu, C. M. S., Sanson, M., Wick, W., Brandes, A. A., Clement, P. M., Erridge, S. C., . . . van den Bent, M. J. (2022). Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: Post hoc analysis of the EORTC randomized phase III CATNON trial. Clinical cancer research, 28(12), . https://doi.org/10.1158/1078-0432.CCR-21-4283

Chicago Style (17th ed.) Citation

Tesileanu, C. Mircea S., et al. "Temozolomide and Radiotherapy Versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial." Clinical Cancer Research 28, no. 12 (2022). https://doi.org/10.1158/1078-0432.CCR-21-4283.

MLA (9th ed.) Citation

Tesileanu, C. Mircea S., et al. "Temozolomide and Radiotherapy Versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial." Clinical Cancer Research, vol. 28, no. 12, 2022, https://doi.org/10.1158/1078-0432.CCR-21-4283.